Our data also support an indirect role of complement activation in mediating the cachexia syndrome, as deletion of C3 also reduced whole-body wasting of muscle and fat, despite no effects on tumor size and minimal effects on the tumor transcriptome. The gene discussed is C3; the disease is Cachexia.